Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare and understudied cancer with a dismal prognosis. SCCOHT's infrequency has hindered empirical study of its biology and clinical management. However, we and others have recently identified inactivating mutations in the SWI/...
Main Authors: | Ramos, Pilar, Karnezis, Anthony N, Hendricks, William P D, Wang, Yemin, Tembe, Waibhav, Zismann, Victoria L, Legendre, Christophe, Liang, Winnie S, Russell, Megan L, Craig, David W, Farley, John H, Monk, Bradley J, Anthony, Stephen P, Sekulic, Aleksandar, Cunliffe, Heather E, Huntsman, David G, Trent, Jeffrey M |
---|---|
Format: | Online |
Language: | English |
Published: |
Taylor & Francis
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755243/ |
Similar Items
-
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
by: Jelinic, Petar, et al.
Published: (2016) -
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
by: Karnezis, Anthony N, et al.
Published: (2015) -
c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations
by: Otte, Anna, et al.
Published: (2015) -
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
by: Moes-Sosnowska, Joanna, et al.
Published: (2015) -
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type
by: Stephens, Bret, et al.
Published: (2012)